The ELAVL3/MYCN positive feedback loop provides a therapeutic target for neuroendocrine prostate cancer.
Ji Y, Zhang W, Shen K, Su R, Liu X, Ma Z, Liu B, Hu C, Xue Y, Xin Z, Yang Y, Li A, Jiang Z, Jing N, Zhu HH, Dong L, Zhu Y, Dong B, Pan J, Wang Q, Xue W.
Ji Y, et al. Among authors: ma z.
Nat Commun. 2023 Nov 28;14(1):7794. doi: 10.1038/s41467-023-43676-3.
Nat Commun. 2023.
PMID: 38016952
Free PMC article.